Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 7Lymphoma 7Lymphoma, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Hairy Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Hematologic Diseases 2Sezary Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Cytokine Release Syndrome 1Burkitt Lymphoma 1

Interventions

Vincristine 3Dexamethasone 3Cyclophosphamide 3blinatumomab 2Prednisone 2Methylprednisolone 2Methotrexate 2Mercaptopurine 2Doxorubicin 2Cytarabine 2venetoclax 1prednylidene 1pegaspargase 1merphos 1fludarabine phosphate 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1asparaginase erwinia chrysanthemi recombinant 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Rituximab 1Radiotherapy 1Radiation 1Prednisolone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Bendamustine Hydrochloride × Clear all
NCT04629729 2026-03-19

FT819 in Subjects With B-cell Malignancies

Fate Therapeutics

Phase 1 Active not recruiting
54 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡